Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin in Obese Adults
NCT03043053Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jul 2017
- Primary completion
- May 2022
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in obesity, sponsored by Massachusetts General Hospital. Started Jul 2017; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03043053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03043053.